Mr. Ron Nagar reports

TEMPRAMED EXPANDS EUROPEAN FOOTPRINT WITH DISTRIBUTION PARTNERSHIP IN NETHERLANDS, BELGIUM, AND LUXEMBOURG

Tempramed Technologies Ltd. has entered into a distribution partnership with Salomo Executive, a leading health care logistics and consultancy company based in the Netherlands. This collaboration marks a strategic expansion into Western Europe, ensuring that Tempramed's VIVI product portfolio becomes widely accessible to consumers across bricks and mortar pharmacies, medical distributors, and medical-focused retail channels.

Salomo Executive is recognized for its strong network throughout Western Europe, primarily the Benelux region (Netherlands, Belgium, Luxembourg), operating within both the health care supply chain and the wider commercial landscape. The company has successfully designed and implemented last-mile delivery solutions for major pharmaceutical brands such as multinational pharmaceutical company, Merck & Co. (MSD), and brings extensive experience in e-commerce and direct-to-consumer models.

Through partnerships with leading pharmacy chains with over 500 locations, as well as numerous independent pharmacies, medical wholesalers and diabetes-focused webshops, Salomo Executive will ensure the efficient and scalable introduction of Tempramed's products across the region.

"We are thrilled to collaborate with Salomo Executive, whose deep expertise in health care logistics and omnichannel distribution aligns perfectly with Tempramed's global growth strategy," said Ron Nagar, chief executive officer of Tempramed. "This partnership marks an important step in our broader expansion across Europe and other key international markets, supported by a series of new product launches designed to enhance the safe storage and usability of temperature-sensitive medications. The Benelux region (Belgium, Netherlands, Luxembourg) represents one of Europe's most advanced health care ecosystems -- particularly in diabetes care, which remains central to our mission. Together with Salomo Executive, we look forward to building a long-term partnership that will accelerate access to Tempramed's innovative solutions across Western Europe and beyond."

Expanding access in a growing market

Looking at diabetes alone, the Netherlands has approximately 1.2 million people living with diabetes, and according to a report from Maastricht University, an additional 1.3 million people in the Netherlands have prediabetes, many of whom are unaware. As the prevalence of diabetes continues to rise, the demand for dependable, temperature-controlled storage for insulin and other injectable medications for chronic diseases has become critical.

Tempramed has a portfolio of temperature regulated products for many variations of injectable medications and will continue to launch new versions into the market. This partnership will enable health care professionals, pharmacies and patients to access Tempramed's patented technology, designed to maintain medication safety and efficacy in everyday life, travel and changing climate conditions.

Tempramed is rapidly expanding its global footprint through a growing network of strategic distribution partnerships designed to accelerate scale and market penetration. Backed by eight international patents and approvals from leading health authorities worldwide, Tempramed is poised to establish itself as the global standard in the safe storage of temperature-sensitive medications.

About Salomo Executive

Salomo Executive operates at the intersection of health care, logistics and commerce, providing distribution and consultancy services to pharmaceutical, medical and retail partners. In addition to direct supply to wholesalers and pharmacies, the company supports organizations with commercial strategy, go-to-market planning and health care operations, ensuring products reach patients efficiently and effectively.

About Tempramed Technologies Ltd.

Tempramed is a global leader in innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, U.S. Food and Drug Administration-registered (FDA), space-grade thermal insulation devices that work 24/7 without batteries or external power. With a proven product line, including VIVI Cap and VIVI Epi, and a smart technology platform on the horizon, Tempramed enables patients and health care providers to confidently manage temperature-sensitive medications anywhere, any time. Headquartered in Israel with operations in North America, Europe and Asia, Tempramed is advancing the future of medication protection and adherence.

We seek Safe Harbor.